Empirical Finance LLC lowered its stake in shares of Herbalife Nutrition Ltd (NYSE:HLF) by 49.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 34,812 shares of the company’s stock after selling 33,736 shares during the period. Empirical Finance LLC’s holdings in Herbalife Nutrition were worth $1,899,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of HLF. Dimensional Fund Advisors LP lifted its position in shares of Herbalife Nutrition by 1.4% during the first quarter. Dimensional Fund Advisors LP now owns 512,861 shares of the company’s stock worth $49,988,000 after acquiring an additional 7,120 shares in the last quarter. BNP Paribas Arbitrage SA lifted its position in shares of Herbalife Nutrition by 124.4% during the first quarter. BNP Paribas Arbitrage SA now owns 1,462 shares of the company’s stock worth $143,000 after acquiring an additional 7,461 shares in the last quarter. Russell Investments Group Ltd. lifted its position in shares of Herbalife Nutrition by 6.0% during the first quarter. Russell Investments Group Ltd. now owns 8,457 shares of the company’s stock worth $824,000 after acquiring an additional 480 shares in the last quarter. Highbridge Capital Management LLC purchased a new stake in shares of Herbalife Nutrition during the first quarter worth $829,000. Finally, Xact Kapitalforvaltning AB lifted its position in shares of Herbalife Nutrition by 35.7% during the first quarter. Xact Kapitalforvaltning AB now owns 7,609 shares of the company’s stock worth $742,000 after acquiring an additional 2,000 shares in the last quarter. Hedge funds and other institutional investors own 88.15% of the company’s stock.
Several equities research analysts have issued reports on HLF shares. Zacks Investment Research downgraded Herbalife Nutrition from a “buy” rating to a “hold” rating in a research report on Tuesday, July 3rd. Pivotal Research restated a “buy” rating and set a $75.00 target price on shares of Herbalife Nutrition in a research report on Thursday, August 2nd. Jefferies Financial Group started coverage on Herbalife Nutrition in a research report on Thursday, October 11th. They set a “buy” rating and a $65.00 target price on the stock. Finally, ValuEngine upgraded Herbalife Nutrition from a “hold” rating to a “buy” rating in a research report on Tuesday. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $60.92.
In other news, COO David Pezzullo sold 99,875 shares of the company’s stock in a transaction on Tuesday, September 18th. The shares were sold at an average price of $55.29, for a total value of $5,522,088.75. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Jeff Dunn sold 17,440 shares of the company’s stock in a transaction on Friday, August 3rd. The stock was sold at an average price of $58.53, for a total transaction of $1,020,763.20. The disclosure for this sale can be found here. In the last ninety days, insiders sold 205,961 shares of company stock worth $11,578,487. Insiders own 6.19% of the company’s stock.
Shares of Herbalife Nutrition stock traded down $0.49 during trading on Thursday, hitting $54.33. The stock had a trading volume of 24,227 shares, compared to its average volume of 1,881,706. The stock has a market cap of $8.57 billion, a P/E ratio of 22.41 and a beta of 0.67. Herbalife Nutrition Ltd has a 12 month low of $32.13 and a 12 month high of $60.41. The company has a debt-to-equity ratio of -1.87, a quick ratio of 0.71 and a current ratio of 0.91.
Herbalife Nutrition (NYSE:HLF) last released its quarterly earnings results on Wednesday, August 1st. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.68 by $0.12. The firm had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.26 billion. Herbalife Nutrition had a net margin of 3.61% and a negative return on equity of 140.85%. The business’s quarterly revenue was up 13.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.51 earnings per share. Sell-side analysts predict that Herbalife Nutrition Ltd will post 2.75 earnings per share for the current year.
About Herbalife Nutrition
Herbalife Nutrition Ltd. develops and sells nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. It provides science-based products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition.
Featured Story: Why is insider trading harmful?
Want to see what other hedge funds are holding HLF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Herbalife Nutrition Ltd (NYSE:HLF).
Receive News & Ratings for Herbalife Nutrition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife Nutrition and related companies with MarketBeat.com's FREE daily email newsletter.